Rakow John 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Rakow John
SVP, Genl Counsel, Acting CFO
Transactions
- Award
Stock Option (Right to Buy)
2022-06-08+250,000→ 250,000 totalExercise: $1.09Exp: 2032-06-07→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of June 3, 2022, and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of June 3, 2022, subject to the Reporting Person's continued service with the Issuer on each such vesting date.